NATURE’S SUNSHINE PRODUCTS, INC. Shareholders' Equity
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Shareholders' Equity of $136.60 million as of 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquity · last filed 2014-11-06
- 2014-09-30: Stockholders' Equity Attributable to Parent $136.60M.
- 2014-06-30: Stockholders' Equity Attributable to Parent $118.19M.
- 2014-03-31: Stockholders' Equity Attributable to Parent $114.58M.
- 2013-12-31: Stockholders' Equity Attributable to Parent $105.26M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2014-09-30 | $136.60M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $118.19M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $114.58M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $105.26M 10-Q · filed 2014-11-06 |
| 2013-09-30 | $104.83M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $122.77M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $118.83M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $115.64M 10-K · filed 2014-03-17 |
| 2012-09-30 | $111.85M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $102.56M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $95.79M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $87.44M 10-K · filed 2014-03-17 |
| 2011-09-30 | $80.39M 10-Q · filed 2011-11-08 |
| 2010-12-31 | $68.38M 10-K · filed 2014-03-17 |
| 2009-12-31 | $57.09M 10-K · filed 2013-03-07 |
| 2008-12-31 | $53.68M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |